BioNan-X Medical is a standout in the CBD marketplace, leveraging the expertise of more than 130 employees, including a leadership team with over 20 years dedicated to CBD. The company's parent network, with a 30-year track record in healthcare, includes affiliates such as VQ OrthoCare, VQ ActionCare, and Pucker Urban Farms. Notably, BioNan-X Medical is the first woman-owned venture in this established network, led by Dorian Knape as the CEO. They have pioneered the use of proprietary nano amplified CBD to address common health challenges, backed by comprehensive studies demonstrating superior bloodstream absorption for more effective results. BioNan-X Medical's portfolio of nano amplified CBD products is accessible via premier retail and wholesale channels and through medical professionals. Additionally, the company supplies nano amplified CBD to various industries, including food and beverage, equine medicine, and veterinary hospitals. Founded in 2021 and headquartered in the United States, BioNan-X Medical presents an attractive investment opportunity in the rapidly evolving health care sector.
There is no investment information
No recent news or press coverage available for BioNan-X Medical.